Apollo Endosurgery has struck a deal to acquire monoclonal antibody-focused Lpath in a reverse merger that will see the Apollo's investors adding ... ...read more
Growth Capitalist (https://growthcapitalist.com/2016/09/apollo-reverse-merges-raises-29m-to-back-obesity-devices/)
Apollo Endosurgery has struck a deal to acquire monoclonal antibody-focused Lpath in a reverse merger that will see the Apollo's investors adding ... ...read more